Insiders GlaxoSmithKline Pharmaceuticals Limited

Equities

GLAXO

INE159A01016

Market Closed - Bombay S.E. Other stock markets 03:30:50 13/05/2024 pm IST			5-day change	1st Jan Change
1,998 ^INR	+1.25%		-4.60%	+5.28%

09/05	Drugmaker Abbott India posts Q4 profit rise on higher sales	RE
25/04	GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology	RE

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cynata Therapeutics Names Chief Business Officer; Shares Plunge 14%	29/02	MT
Glaxosmithkline Pharmaceuticals Limited Appoints Aparajita Mukherjee Rajput, Technology Lead	28/02	CI
GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Sunder Ramachandran as Head of Commercial Excellence, Effective 12 January 2024	29/12	CI
GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Abhinav Kashyap as Pharma Technology Lead	06/12	CI
GlaxoSmithKline Pharmaceuticals Limited Appoints Omkar Parnandiwar as Head of Omnichannel, Effective November 1, 2023	31/23/31	CI
GlaxoSmithKline Pharmaceuticals Names New Managing Director	17/22/17	MT
GlaxoSmithKline Pharmaceuticals Limited Announces Executive Changes	17/22/17	CI
Glaxosmithkline Pharmaceuticals Limited Announces Resignation of Nihal Kaviratne as Board Member	25/22/25	CI
GlaxoSmithkline Pharmaceuticals Limited Announces Nihal Kaviratne Voluntarily Relinquished as Board Member, Effective July 26, 2022	25/22/25	CI
GlaxoSmithkline Pharmaceuticals Limited Announces Resignation of Mark Dawson as Non- Executive Director	16/22/16	CI
GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Manu Anand as Additional Independent Director	16/22/16	CI
GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Juby Chandy as Chief Financial Officer	21/22/21	CI
GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Juby Chandy as A Whole-Time Director	21/22/21	CI
GlaxoSmithKline Pharmaceuticals Limited Announces Executive Changes	07/22/07	CI
Glaxosmithkline Pharmaceuticals Limited Approves Directorate Changes	07/21/07	CI
GlaxoSmithKline Pharmaceuticals Limited Recommends Common and Special Dividend for the Year Ended March 31, 2020; Appoints Sunita Maheshwari as an Additional Independent Director	18/20/18	CI
GlaxoSmithKline Pharmaceuticals Limited Announces Managing Director Changes, Effective 1 April 2020	03/20/03	CI
GlaxoSmithkline Pharmaceuticals Limited Announces Board Changes	28/19/28	CI
GlaxoSmithkline Pharmaceuticals Limited Announces Change in Directorate	24/18/24	CI
GlaxoSmithkline Pharmaceuticals Limited Announces Cessation of Mr. Andrew Aristidou to Be A Director & CFO	16/18/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders GlaxoSmithKline Pharmaceuticals Limited

Equities

GLAXO

INE159A01016

Insiders

Filters